Log In
BCIQ
Print this Print this
 

Tramal, tramadol hydrochloride (NS-315)

  Manage Alerts
Collapse Summary General Information
Company Gruenenthal Group
DescriptionTramadol
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat cancer pain; Treat chronic pain; Treat moderate to severe pain
Regulatory Designation
PartnerNippon Shinyaku Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/19/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today